USFDA approves Pfizer’s Covid-19 vaccine for individuals aged 12 to 15 years
The FDA authorisation is based on data from a pivotal Phase 3 clinical trial, which enrolled 2,260 individuals…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
11 May 21
The FDA authorisation is based on data from a pivotal Phase 3 clinical trial, which enrolled 2,260 individuals…
10 May 21
The anti-Covid-19 oral drug has been developed by INMAS, a lab of DRDO, in partnership with Hyderabad-based Dr…
06 May 21
The approval is based on data from the Phase 3 clinical trial, which enrolled 2,260 adolescents aged 12…
06 May 21
The EC approval represents Tecentriq’s fourth indication in metastatic NSCLC and fifth indication in lung cancer overall in…
03 May 21
Farxiga is said to have reduced the risk of the composite of worsening of renal function, end-stage kidney…
03 May 21
The company filed its sBLA application based on the Phase 3 CheckMate -274 trial, in which Opdivo increased…
30 Apr 21
Ogluo is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged two years and…
26 Apr 21
GSK claimed that its Jemperli is the first anti-PD-1 therapy approved for recurrent or advanced endometrial cancer
26 Apr 21
Use of J&J’s single-shot Covid-19 vaccine was paused after the vaccination induced a rare and severe thrombosis with…
23 Apr 21
The FDA accelerated approval is based on the results from the dMMR endometrial cancer cohort of the ongoing…